Hep B VX CLINICAL TRIAL was 147 Children / 5 days - "In three clinical studies, 434 doses of RECOMBIVAX HB, 5 mcg, were administered to 147

Name: Hep B VX CLINICAL TRIAL was 147 Children / 5 days - "In three clinical studies, 434 doses of RECOMBIVAX HB, 5 mcg, were administered to 147
Uploaded: 2026-03-31
Description: Hep B VX CLINICAL TRIAL was 147 Children / 5 days - "In three clinical studies, 434 doses of RECOMBIVAX HB, 5 mcg, were administered to 147 healthy infants and children (up to 10 years of age) who were monitored for 5 days after each dose" LINK: FULL DOCUMENTARY:

2026-03-31 ·

Watch on Facebook ↗

About this video

Hep B VX CLINICAL TRIAL was 147 Children / 5 days - "In three clinical studies, 434 doses of RECOMBIVAX HB, 5 mcg, were administered to 147 healthy infants and children (up to 10 years of age) who were monitored for 5 days after each dose" LINK: FULL DOCUMENTARY:

This entry reproduces source material or commentary; its claims are not independently verified by this archive.